{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:12:23Z","timestamp":1791357143641,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.schres.2005.01.003","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T13:34:53Z","timestamp":1110548093000},"page":"59-68","source":"Crossref","is-referenced-by-count":395,"title":["From dopamine to salience to psychosis\u2014linking biology, pharmacology and phenomenology of psychosis"],"prefix":"10.1016","volume":"79","author":[{"given":"Shitij","family":"Kapur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.schres.2005.01.003_bib1","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.schres.2005.01.003_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","article-title":"Delayed-onset hypothesis of antipsychotic action\u2014a hypothesis tested and rejected","volume":"60","author":"Agid","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1037\/0735-7044.114.2.389","article-title":"Different inhibition of conditioned avoidance response by clozapine and DA D1 and D2 antagonists in male mice","volume":"114","author":"Aguilar","year":"2000","journal-title":"Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0163-1047(82)90903-7","article-title":"Effects of dopamine receptor blockade on avoidance performance: assessment of effects on cue-shock and response-outcome associations","volume":"36","author":"Anisman","year":"1982","journal-title":"Behav. Neural Biol."},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/19.3.609","article-title":"Subjective response to neuroleptics in schizophrenia","volume":"19","author":"Awad","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2005.01.003_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.1994.tb05828.x","article-title":"Subjective response to neuroleptics and the quality of life: implications for treatment outcome","volume":"380","author":"Awad","year":"1994","journal-title":"Acta Psychiatr. Scand., Suppl."},{"issue":"4","key":"10.1016\/j.schres.2005.01.003_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/002076409904500405","article-title":"Quality of life and new antipsychotics in schizophrenia. Are patients better off?","volume":"45","author":"Awad","year":"1999","journal-title":"Int. J. Soc. Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.schres.2005.01.003_bib8","first-page":"123","article-title":"Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life","volume":"10","author":"Awad","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2005.01.003_bib9","series-title":"Well being: the foundations of hedonic psychology","first-page":"525","article-title":"Pleasure, pain, desire and dread: hidden core processes of emotion","author":"Berridge","year":"1999"},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","article-title":"What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?","volume":"28","author":"Berridge","year":"1998","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.schres.2005.01.003_bib11","series-title":"Psychopharmacology of aversively motivated behavior","first-page":"385","article-title":"Effects of neuroleptics, ethanol, hypnotic-sedatives, tranquilizers, narcotics, and minor stimulants in aversive paradigms","author":"Bignami","year":"1978"},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/archpsyc.1968.01740090092009","article-title":"Pathogenesis of acute schizophrenic psychosis. An experimental approach","volume":"19","author":"Bowers","year":"1968","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2005.01.003_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.1960.03590080086012","article-title":"Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo","volume":"2","author":"Casey","year":"1960","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2005.01.003_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/ajp.117.2.97","article-title":"Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital","volume":"117","author":"Casey","year":"1960","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2005.01.003_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-1014355","article-title":"Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses","volume":"26","author":"Ceskova","year":"1993","journal-title":"Pharmacopsychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2005.01.003_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(99)00012-2","article-title":"A rating scale for psychotic symptoms (RSPS): Part I. Theoretical principles and subscale 1: perception symptoms (illusions and hallucinations)","volume":"38","author":"Chouinard","year":"1999","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00427637","article-title":"Stimulus efficacy, chlorpromazine, and schizophrenia","volume":"69","author":"Clody","year":"1980","journal-title":"Psychopharmacology"},{"issue":"2:2","key":"10.1016\/j.schres.2005.01.003_bib18","first-page":"267","article-title":"Therapeutic method derived from hiberno-therapy in excitation and agitation states","volume":"110","author":"Delay","year":"1952","journal-title":"Ann. Med. Psychol. (Paris)"},{"issue":"5 Pt 2","key":"10.1016\/j.schres.2005.01.003_bib19","first-page":"29","article-title":"Drugs and the quality of life: the patient's point of view","volume":"46","author":"Diamond","year":"1985","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2005.01.003_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bmj.2.4887.560","article-title":"Effect of chlorpromazine on the behaviour of chronically overactive psychotic patients","volume":"2","author":"Elkes","year":"1954","journal-title":"Br. Med. J."},{"key":"10.1016\/j.schres.2005.01.003_bib21","first-page":"647","article-title":"Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems","volume":"vol. 4","author":"Fibiger","year":"1986"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(75)90114-4","article-title":"Haloperidol-induced disruption of conditioned avoidance responding: attenuation by prior training or by anticholinergic drugs","volume":"30","author":"Fibiger","year":"1975","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2005.01.003_bib23","first-page":"427","article-title":"Mind and brain in psychiatric treatment","volume":"58","author":"Gabbard","year":"1994","journal-title":"Bull. Menninger Clin."},{"key":"10.1016\/j.schres.2005.01.003_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0447.1999.tb05990.x","article-title":"Subjective experience and mental side-effects of antipsychotic treatment","volume":"395","author":"Gerlach","year":"1999","journal-title":"Acta Psychiatr. Scand., Suppl."},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","article-title":"Neuroleptic withdrawal in schizophrenic patients. A review of the literature","volume":"52","author":"Gilbert","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2005.01.003_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchemneu.2003.10.003","article-title":"The primate basal ganglia: parallel and integrative networks","volume":"26","author":"Haber","year":"2003","journal-title":"J. Chem. Neuroanat."},{"issue":"5","key":"10.1016\/j.schres.2005.01.003_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s001150050454","article-title":"Anhedonia\u2014a general nosology surmounting correlate of a dysfunctional dopaminergic reward system?","volume":"70","author":"Heinz","year":"1999","journal-title":"Nervenarzt"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0033291700030282","article-title":"Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures","volume":"22","author":"Hogan","year":"1992","journal-title":"Psychol. Med."},{"issue":"8069","key":"10.1016\/j.schres.2005.01.003_bib29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","article-title":"Mechanism of the antipsychotic effect in the treatment of acute schizophrenia","volume":"1","author":"Johnstone","year":"1978","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0920-9964(99)00204-2","article-title":"Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire","volume":"45","author":"Kampman","year":"2000","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2005.01.003_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"8","key":"10.1016\/j.schres.2005.01.003_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2004.06.005","article-title":"How antipsychotics become anti-\u2018psychotic\u2019\u2014from dopamine to salience to psychosis","volume":"25","author":"Kapur","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.schres.2005.01.003_bib33","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2005.01.003_bib35","article-title":"Immediate onset of the anti-psychotic effect: the early onset hypothesis","author":"Kapur","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2005.01.003_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1176\/appi.ajp.158.7.989","article-title":"A psychiatric dialogue on the mind\u2013body problem","volume":"158","author":"Kendler","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2005.01.003_bib37","first-page":"1321","article-title":"L' hibernation artificielle par moyen pharmacodynamique et physisques","volume":"59","author":"Laborit","year":"1951","journal-title":"Presse Med."},{"key":"10.1016\/j.schres.2005.01.003_bib38","article-title":"The early onset of antipsychotic effect\u2014a hypothesis tested, confirmed and extended","author":"Leucht","year":"2004"},{"issue":"5","key":"10.1016\/j.schres.2005.01.003_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","article-title":"Schizophrenia as a disorder of neurodevelopment","volume":"25","author":"Lewis","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2005.01.003_bib42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.pbb.2004.05.023","article-title":"Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases","volume":"78","author":"Li","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.schres.2005.01.003_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2003.09.013","article-title":"Effects of typical and atypical antipsychotic drugs on maternal behavior in postpartum female rats","volume":"70","author":"Li","year":"2004","journal-title":"Schizophr. Res."},{"issue":"1 Suppl 1","key":"10.1016\/j.schres.2005.01.003_bib43","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00004714-199502001-00001","article-title":"The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics","volume":"15","author":"Meltzer","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2005.01.003_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00176470","article-title":"The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness","volume":"92","author":"Miller","year":"1987","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00048678909062141","article-title":"Hyperactivity of associations in psychosis","volume":"23","author":"Miller","year":"1989","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2005.01.003_bib46","unstructured":"Mizrahi, R., Bagby, M., Zipursky, R., Kapur, S., in press. How antipsychotics work: the patients' perspective. Progress in Neuropsychopharmacology. in press."},{"issue":"6932","key":"10.1016\/j.schres.2005.01.003_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature01476","article-title":"Subsecond dopamine release promotes cocaine seeking","volume":"422","author":"Phillips","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.schres.2005.01.003_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00408321","article-title":"An analysis of chlorpromazine-induced suppression of the avoidance response","volume":"3","author":"Ponsluns","year":"1962","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.schres.2005.01.003_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1192\/bjp.161.3.298","article-title":"The origins of delusion","volume":"161","author":"Roberts","year":"1992","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0166-4328(94)90153-8","article-title":"The involvement of nucleus accumbens dopamine in appetitive and aversive motivation","volume":"61","author":"Salamone","year":"1994","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.schres.2005.01.003_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14728222.8.6.631","article-title":"The search for novel antipsychotics: pharmacological and molecular targets","volume":"8","author":"Sanger","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0896-6273(02)00967-4","article-title":"Getting formal with dopamine and reward","volume":"36","author":"Schultz","year":"2002","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0959-4388(97)80008-6","article-title":"Neural basis of utility estimation","volume":"7","author":"Shizgal","year":"1997","journal-title":"Curr. Opin. Neurobiol."},{"issue":"7","key":"10.1016\/j.schres.2005.01.003_bib54","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1185\/030079904125004033","article-title":"Quetiapine in schizophrenia: onset of action within the first week of treatment","volume":"20","author":"Small","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0166-4328(98)00108-9","article-title":"Maternal motivation of lactating rats is disrupted by low dosages of haloperidol","volume":"99","author":"Stern","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.schres.2005.01.003_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1192\/bjp.184.3.231","article-title":"Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial","volume":"184","author":"Tarrier","year":"2004","journal-title":"Br. J. Psychiatry."},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.mp.4001009","article-title":"Significant dissociation of brain and plasma kinetics with antipsychotics","volume":"7","author":"Tauscher","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2005.01.003_bib58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","article-title":"Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses","volume":"42","author":"Thompson","year":"2000","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archpsyc.1981.01780270073010","article-title":"Subjective response to antipsychotic drugs","volume":"38","author":"Van Putten","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2005.01.003_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0920-9964(01)00161-X","article-title":"Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia","volume":"56","author":"Voruganti","year":"2002","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2005.01.003_bib61","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2002.01005.x","article-title":"Transient changes in mesolimbic dopamine and their association with \u2018reward\u2019","volume":"82","author":"Wightman","year":"2002","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.schres.2005.01.003_bib62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev., Neurosci."},{"issue":"4352","key":"10.1016\/j.schres.2005.01.003_bib63","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.566469","article-title":"Neuroleptic-induced \u201canhedonia\u201d in rats: pimozide blocks reward quality of food","volume":"201","author":"Wise","year":"1978","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.schres.2005.01.003_bib64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/schbul\/22.2.353","article-title":"The prodromal phase of first-episode psychosis: past and current conceptualizations","volume":"22","author":"Yung","year":"1996","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640500037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640500037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T11:28:43Z","timestamp":1549193323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099640500037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S092099640500037X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2005.01.003","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}